Menopausal disorders and symptoms of ovarian deficiency
- Medication Guidance
- Medication Q&A
- Popular Drugs
- New Drugs
-
Precautions for using digotinib ointment: local irritation, skin barrier function, and long-term safety
-
Delgocitinib contraindicated population: active infections in external application areas and allergies to the ingredients of this product
-
Management of side effects of digotinib ointment: how to deal with local burning, dryness, and erythema
-
Delgocitinib External Use Guide
-
Precautions for taking terbotinib: monitoring of edema, pulmonary, hepatic, and pancreatic toxicity
-
Taboo population of terbotinib: liver and kidney dysfunction, pregnancy and breastfeeding precautions
-
Management of side effects of terbotinib: coping with diarrhea, nausea, and fatigue
-
Tepotinib Usage Guidelines: With Meal, Dosage, and Omission Management
-
Precautions for taking Luketinib: risk of infection, thrombocytopenia, hepatotoxicity, and non melanoma skin cancer
-
Ruxolitinib taboo population: instructions for active severe infection and non screened tuberculosis patients
-
Management of side effects of Luketinib: How to deal with dizziness, bruising, and weight gain
-
Ruxolitinib medication guide: on an empty stomach or with meals? Dose adjustment and treatment of missed doses
